¾Ë·¯Á¨ Á¦°Å ¿Ì³ª¹« ÃßÃâ¹° Åõ¿©·Î »ýÁ¸±â°£ÀÌ ¿¬ÀåµÈ 4±â ºñ¼Ò¼¼Æ÷¼ºÆó¾Ï ȯÀÚ 1·Ê
A Case Report of a Patient with Advanced Non-Small Cell Lung Cancer Treated with Allergen Removed Rhus Verniciflua Stokes (aRVS)

´ëÇѾÏÇÑÀÇÇÐȸÁö 2012³â 17±Ç 1È£ p.45 ~ p.53

ÃÖ¼ºÇå(Choi Seong-Heon) - °æÈñ´ëÇб³ °­µ¿°æÈñ´ëÇб³º´¿ø Çѹæ¾Ï¼¾ÅÍ
¼Û¾È³ª(Song An-Na) - °æÈñ´ëÇб³ °­µ¿°æÈñ´ëÇб³º´¿ø Çѹæ¾Ï¼¾ÅÍ
¾ÈÁöÇý(An Ji-Hye) - °æÈñ´ëÇб³ °­µ¿°æÈñ´ëÇб³º´¿ø Çѹæ¾Ï¼¾ÅÍ
±èÀºÈñ(Kim Eun-Hee) - °æÈñ´ëÇб³ °­µ¿°æÈñ´ëÇб³º´¿ø Çѹæ¾Ï¼¾ÅÍ
¹Ú¼ÒÁ¤(Park So-Jung) - °æÈñ´ëÇб³ °­µ¿°æÈñ´ëÇб³º´¿ø Çѹæ¾Ï¼¾ÅÍ
À̼ö°æ(Lee Soo-Kyung) - °æÈñ´ëÇб³ ´ëÇпø ÀÓ»óÁ¾¾çÇаú
±è°æ¼®(Kim Kyung-Suk) - °æÈñ´ëÇб³ °­µ¿°æÈñ´ëÇб³º´¿ø Çѹæ¾Ï¼¾ÅÍ

Abstract

Objective : We introduce a case of non-small cell lung cancer patient treated with allergen removed Rhus verniciflua Stokes.

Methods : This patient started Allergen-removed Rhus Verniciflua Stokes from Feb 2010 right after his firstline chemotherapy, and maintained his Oriental medicine regimen until now.

Results : It shows 12.0 months of progression-free-survival since starting point of maintenance chemotherapy, and 9.3 months of overall-survival since progression disease after 2nd chemotherapy, compared with 6.3 months of its known overall survival.

Conclusion : Allergen removed Rhus verniciflua Stokes prolonged overall survival and slowed disease progression of a non-small cell lung cancer patient.

Å°¿öµå

Advanced non-small cell lung cancer, overall survival, aRVS
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Allergen removed Rhus verniciflua Stokes prolonged overall survival and slowed disease progression of a non-small cell lung cancer patient.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå